EQS-News: INDUS Holding AG / Key word (s): Takeover INDUS acquires British company COLSON X-Cel in the future field of measurement and control technology 27.03.2024 / 08:10 CET/CEST The issuer is ...
On what oth­er­wise would have been any or­di­nary, rou­tine day in Pitts­burgh, the peo­ple of the South Side were ...
New animated film Max Beyond can be pre-ordered on Apple TV right now, with a release date set for April 22nd. The film is ...
Adaptimmune Therapeutics plc (NASDAQ: ADAP), a company redefining the treatment of solid tumor cancers with cell therapy, ...
CEL-SCI’s LEAPS vaccine offers promising new paradigm to treat rheumatoid arthritis: published in Frontiers in Immunology.
In 2026, the United States will host the FIFA World Cup alongside fellow North American nations Mexico and Canada, and after ...
St. Jude Children’s Research Hospital scientists reversed an aggressive cancer, reverting malignant cells towards a more ...
The approval fills a void for patients with CLL or SLL whose disease progresses after treatment with a BTK inhibitor or a BCL ...
The maximum temperature is likely to rise gradually by 2-3 degrees Celsius during the next 5 days, Meteorological Centre said on Wednesday.
Endpoints News won a general excellence award from the Society for Advancing Business Editing and Writing, and was a finalist ...
The approval makes atidarsagene autotemcel (arsa-cel [Lenmeldy]; Orchard Therapeutics) the first approved treatment for metachromatic leukodystrophy, a disease caused by a mutation in the ARSA gene ...
During an Oncologic Drug Advisory Committee Meeting, the FDA found that ciltacabtagene autoleucel has a favorable ...